Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
09/2005
09/27/2005US6949536 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
09/22/2005WO2005087779A1 Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087719A1 Stereoselective synthesis of vitamin d analogues
09/22/2005WO2005087708A1 Phenyl indan derivatives
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005US20050209233 Neuropeptide Y5 (NPY-5) receptor antagonists or agonists; eating disorders, diabetes dyslipidemia, hypertension, and sleep disorders; pyridazin-3-ylamino-substituted dibenzothiophenes and S-oxides thereof
09/22/2005US20050208402 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/21/2005EP1577294A1 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method
09/21/2005EP1577289A1 Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1575964A2 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
09/21/2005EP1575961A1 Method for the decarboxylation of dicarboxylic acids
09/21/2005EP1575933A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors
09/21/2005EP1575932A2 Octupolar molecules used as organic semi-conductors
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575903A1 Compounds for the inhibition of rotamases
09/21/2005EP1575575A2 Safe chemical uncouplers for the treatment of obesity
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005CN1671688A Process for producing 2-alkyl-3-aminothiophene derivative
09/21/2005CN1671687A Method for the production of (s)-3-methylamino-1-(thien-2-yl)propan-1-ol
09/21/2005CN1671686A Process for producing n-monoalkyl-3-hydroxy-3-(2-thienyl)propanamine and intermediate
09/21/2005CN1671685A Process for the preparation of 3-hydroxy-(2-thienyl)propanamines
09/21/2005CN1671651A N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1671375A Improved transdermal delivery system for the administration of rotigotine
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1219777C Thiophene vitamine A
09/21/2005CN1219776C Thiophene substituted amine derivatives as GLYT-1 inhibitors
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946559 Method of converting functional group through halogen-metal exchange reaction
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946483 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
09/20/2005US6946466 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085192A1 Method for producing n-alkyl-n-methyl-3-hydroxy-3-(2-thienyl)-propylamines
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2005085176A1 π-CONJUGATED AROMATIC RING-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE
09/15/2005WO2005084803A1 Asymmetric reaction catalyst and process for production of optically active compounds with the same
09/15/2005WO2005065050A3 Bicyclic compound
09/15/2005US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
09/15/2005US20050203172 Novel compounds
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203081 Inhibitors of protein tyrosine phosphatase 1B
09/15/2005CA2556994A1 Method for producing n-alkyl-n-methyl-3-hydroxy-3-(2-thienyl)-propylamines
09/14/2005EP1573391A2 Second order nonlinear optical chromophores, polymers containing same, and electro-optic devices therefrom
09/14/2005EP1572677A1 Preparation of heterocyclic ketones
09/14/2005EP1572663A1 Biphenylcarboxamides
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
09/14/2005EP1572612A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005CN1668665A Process for producing dendrimer, thiophene compound, and process for producing thiophene compound
09/14/2005CN1668303A Selective estrogen receptor modulators containing a phenylsulfonyl group
09/09/2005WO2005082882A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005082350A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
09/09/2005WO2005081960A2 Inhibitors of protein tyrosine phosphatase 1b
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005058867A8 Benzothiophene-and thiochromene containing phenethanolamine derivatives for the treatment of respiratory disorders
09/09/2005CA2557444A1 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
09/09/2005CA2554439A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
09/08/2005US20050197503 Asymmetric hydrogenation of prochiral 1-(N-alkyl-N-methylamino)-3-(2-thienyl)-propan-3-one in the presence of rhodium and a chiral bidentate phosphine ligand catalyst system ; high optical and chemical purity
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050196813 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/08/2005DE102004006785A1 Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure Process for carbon-carbon bond between electrophilic substrates and TT compounds in neutral to basic aqueous or alcoholic solvents without the use of a Lewis or protic acid
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1569941A1 Anthelmintic and insecticidal thiohene compositions
09/07/2005EP1569929A1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS
09/07/2005EP1569924A2 Nf-kb inhibitors
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1088842B1 Optically active polythiophene
09/07/2005CN1665904A Luminescent compositions
09/07/2005CN1665802A Bisarylsulfonamide compounds and their use in cancer therapy
09/07/2005CN1665801A Anti tubercular drug: compositions and methods
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665773A Process for the preparation of i n /i -monosubstituted beta-amino alcohols
09/07/2005CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases
09/07/2005CN1663953A Process for synthesizing benzofuran and benzothiophene heterocyclic compounds
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217931C Spirocyclic phenyl keto-enols as pesticides and herbicides
09/07/2005CN1217920C Compounds to treat Alzheimer disease